Co-Director, Bone Marrow/Stem Cell Transplantation; Bone Marrow / Stem Cell Transplantation Program; Associate Professor, Medicine; Member, JCCC Clinical/Translational, UCLA School of Medicine
Hematology
Dr. Christos E. Emmanouilides, MD
|
|
Give Review
Christos Emmanouilides practices Hematology. Christos E. Emmanouilides, MD is also published. He has 52 publications published. The lastest publication: "Murine IL-10 fails to reduce GVHD despite inhibition of alloreactivity in vitro.'
Publications
- Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma.
- Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent,...
- Amelioration of graft versus host disease by galectin-1.
- Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.
- Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
- A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma.
- Preliminary experience with bevacizumab in combination with standard chemotherapeutic regimens in the treatment of non-small cell lung cancer: a retrospective study.
- Adrenalectomy for solitary adrenal metastasis from colorectal cancer: A case report.
- Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II st...
- Opportunistic infections in oncologic patients.
- Immunotherapeutic and immunoregulatory drugs in haematologic malignancies.
- [Radioimmunotherapy for non-Hodgkin lymphoma: historical development and current status].
- A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin''s disease or non-Hodgkin''s lymphoma.
- Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoin...
- Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
- Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-Hodgkin's lymphoma.
- Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer.
- Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin''s lymphoma.
- Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
- Radioimmunotherapy for non-Hodgkin's lymphoma.
- Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.
- Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin...
- Potentiation of fludarabine cytotoxicity on non-Hodgkin''s lymphoma by pentoxifylline and rituximab.
- Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma ...
- Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous st...
- Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.
- Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lin...
- Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment.
- Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: a phase II trial.
- Detection of bcl-2/IgH rearrangements by quantitative-competitive PCR and capillary electrophoresis.
- Radioimmunotherapy for Waldenstrom's macroglobulinemia.
- Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.
- Infections in liver transplant recipients.
- Extended rituximab therapy in Waldenström's macroglobulinemia.
- Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of ...
- The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat.
- Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma.
- Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete ...
- Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL.
- A randomized phase II study of amifostine used as stem cell protectant in non-hodgkin lymphoma patients receiving cisplatin-based salvage chemotherapy prior to stem ce...
- Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma.
- Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leuk...
- Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
- A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
- Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma.
- Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
- Establishment of an animal model for Waldenström's macroglobulinemia.
- HTLV-I-associated myelopathy following allogeneic bone marrow transplantation.
- Murine IL-10 fails to reduce GVHD despite inhibition of alloreactivity in vitro.
- Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report.
- Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function.
Schools
University of Athens College of Medicine School of Health Science National amp Kapodistrian
Mt Sinai Hospital
University Conn
University Of California Los Angeles
Doctors Specialties
- Infectious Disease Medicine
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
UCLA Medical Center -
Mount Sinai Hospital -
University of Athens
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Sanjay Sharma, MD |
|
|
Dr. Marjorie L. Bernstein-Singer, MD |
|
|
Dr. Vinod Pullarkat, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Vasanth K. Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna M. Schaenman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank J. Latino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Britta Lassmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Goetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hui Zhao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Quinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew M. Denicola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Quen J. Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Fulcher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Malin, MD
This Doctor is OpenDoctor Recommended.
|